Literature DB >> 31698570

Integrated network analysis to explore the key mRNAs and lncRNAs in acute myocardial infarction.

Li Shui Shen1, Xiao Feng Hu1, Ting Chen2,3, Gui Lin Shen2,3, Dong Cheng2,3.   

Abstract

Acute myocardial infarction (AMI) is the most severe cardiovascular event in the world. However, the molecular mechanisms underlying AMI remained largely unclear. Recently, long non-coding RNAs (lncRNAs) were reported to play important roles in human diseases. In the present work, we analyzed a public dataset GSE48060 to confirm key lncRNAs and mRNAs in AMI. We observed 4835 mRNAs and 442 lncRNAs were significantly differently expressed in AMI. Then, we for the first time constructed PPI networks and lncRNA co-expression networks in AMI. The protein-protein interaction (PPI) networks revealed several mRNAs such as RHOA, GNB1, GNG, RAC1, FBXO32, DET1, MEX3C and HECTD1 functioned as key regulators in AMI. LncRNA co-expression network analysis showed 8 lncRNAs (CA5BP1, LOC101927608, BZRAP1-AS1, EBLN3, FGD5-AS1, HNRNPU-AS1, LINC00342, and LOC101927204) played key roles in AMI. Gene ontology (GO) analysis demonstrated these differently expressed lncRNAs were associated with more signaling pathways, such as regulating transcription, protein amino acid phosphorylation, signal transduction, development. Taken together, our research unveiled a series of key lncRNAs and mRNAs in AMI. Several lncRNAs, including CA5BP1, LOC101927608, BZRAP1-AS1, EBLN3, FGD5-AS1, HNRNPU-AS1, LINC00342, and LOC101927204 were identified as key lncRNAs. PPI networks were constructed to reveal key mRNAs in AMI. These results provided useful information for exploring novel molecular target therapy for AMI.

Entities:  

Keywords:  acute myocardial infarction ; differentially expressed gene ; long non-coding RNA ; protein-protein interaction analysis

Year:  2019        PMID: 31698570     DOI: 10.3934/mbe.2019321

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  6 in total

1.  HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.

Authors:  Zhaoyuan Niu; Fengling Wang; Shihui Lv; Yingpin Lv; Ming Liu; Lei Fu; Yushuang Yao; Lingzhi Wang; Wei Lin; Fang Yuan
Journal:  Mol Cell Biol       Date:  2021-07-26       Impact factor: 4.272

2.  Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases.

Authors:  Zsófia Gál; András Gézsi; Ágnes F Semsei; Adrienne Nagy; Monika Sultész; Zsuzsanna Csoma; Lilla Tamási; Gabriella Gálffy; Csaba Szalai
Journal:  J Transl Med       Date:  2020-11-10       Impact factor: 5.531

3.  Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes.

Authors:  Yongdi Wang; Jian Wang
Journal:  Diabetol Metab Syndr       Date:  2022-01-28       Impact factor: 3.320

4.  FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577.

Authors:  Wei-Tao Zhang; Ji-Jun Zhang; Quan Shao; Ying-Kai Wang; Jie-Peng Jia; Bo Qian; Xiao-Wen Tian; Wen-Ji Yan
Journal:  Oncol Rep       Date:  2021-11-25       Impact factor: 3.906

5.  lncRNA FGD5 antisense RNA 1 upregulates RORA to suppress hypoxic injury of human cardiomyocyte cells by inhibiting oxidative stress and apoptosis via miR‑195.

Authors:  Xinyong Cai; Ping Zhang; Shu Wang; Lang Hong; Songping Yu; Bin Li; Hong Zeng; Xu Yang; Liang Shao
Journal:  Mol Med Rep       Date:  2020-10-02       Impact factor: 2.952

Review 6.  Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases.

Authors:  Ting-Wei Kao; Chin-Chou Huang
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.